TRexBio Prices $116.7 Million Initial Public Offering
MT Newswires Live
Yesterday
TRexBio (TRXB) said Thursday it priced its initial public offering of roughly 8.3 million common shares at $14 per share.
The company expects to raise roughly $116.7 million in gross proceeds from the sale, and its stock is expected to begin trading Friday on the Nasdaq Global Select Market (NDAQ) under the ticker symbol TRXB, the company said.
Underwriters have a 30-day option to buy up to an additional 1.25 million shares, and the transaction is expected to close Oct. 13, pending customary conditions, TRexBio said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.